New Horizons Project 2023

Overview

With funding from Johnson & Johnson, and in partnership with the Ministry of Health, EGPAF provides technical assistance on pediatric second- and third-line antiretroviral therapy (ART) access. This project improves sustainable ART service delivery for children and confronts challenges that adolescents face around disclosure, adherence, and psychosocial support. The heart of the Collaborative is a darunavir/etravirine donation program, which increased the availability of second- and third-line pediatric ART.